Showing results (221-230 of 448) with videos related to

Sort By:
Pageof 45
Dermatology (Basel, Switzerland)|January 1, 1996
Are acantholysis and transglutaminase inhibition related phenomena?C Esposito, V Ruocco, A Cozzolino, et al.
British Journal of Cancer|March 1, 1980
Patterns of cyclic nucleotides in normal and leukaemic human leucocytesM Peracchi, A T Maiolo, L Lombardi, et al.
International Journal of Cancer|November 28, 2000
T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigensA J Bremers, S Andreola, E Leo, et al.
The American Journal of Surgical Pathology|November 1, 1991
Argyrophilic carcinoma of the male breast. A neuroendocrine tumor containing predominantly chromogranin B (secretogranin I)L Scopsi, S Andreola, R Saccozzi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancerL Mariani, B Salvadori, E Marubini, et al.
European Review for Medical and Pharmacological Sciences|March 5, 2005
Does rifaximin prevent complications of diverticular disease? A retrospective studyM A Pistoia, L Lombardi, M Rossi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 31, 2012
Detection of possible factors favouring the evolution of migraine without aura into chronic migraineG C Manzoni, L L Lombardi, S Lana, et al.
The American Journal of Cardiology|February 14, 2026
Outcomes of Same-Day Discharge in Chronic Total Occlusion Percutaneous Coronary InterventionSant Kumar, Sudhir Thotakura, Primero Ng, et al.
European Journal of Haematology|November 1, 1987
Inhibitory activity of a synthetic pentapeptide on leukaemic myelopoiesis both in vitro and in vivo in ratsP Foa, F Chillemi, L Lombardi, et al.
Cell Motility and the Cytoskeleton|January 1, 1990
Ultrastructural cytoskeleton alterations and modification of actin expression in the NIH/3T3 cell line after transformation with Ha-ras-activated oncogeneL Lombardi, D Ballinari, I Bongarzone, et al.
Pageof 45